Our observations integrate proteomic, metabolomic, and transcriptomic studies in cell lines, primary human tumor samples, and various public datasets and suggest that convergent mechanisms of WNT4 dysregulation drive cancer metabolism. Here, WNT4 is linked to neoplasm.